Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1912 of 5804
-
Phone app spots seizures in kids
Diagnosis CompletedThis study is being done to find out if a smartphone app can identify absence seizures. Children who have a history of absence seizures, as well as children without any seizure history, will be testing out the app. If participating the child will be guided through hyperventilatio…
Sponsor: Eysz, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
Can a virtual exercise program get inactive adults moving? a new study aims to find out.
Disease control TerminatedThe present study aims to test the efficacy of a multi-level telehealth intervention to Enhance Physical Activity (EPA) in 300 low-income Black and Hispanic/Latino adults. EPA is eight weeks with four weekly, hour-long parts: virtual group exercises, virtual group discussions, in…
Phase: NA • Sponsor: Boston University Charles River Campus • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Shape-Memory staple aims to speed healing of arthritic finger joints
Disease control Recruiting nowArthrodesis of a distal interphalangeal joint of the finger (DIP) is mainly performed for a degenerated and painful joint. Various stabilization methods have been used to provide compression at the arthrodesis site such as pins, steel wires, compression screws, headless compressi…
Phase: NA • Sponsor: Clinique Saint François, Nice, France • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New cough pill shows promise in clinical trial
Symptom relief CompletedThe main purpose of this study is to evaluate the effect of NAL ER on 24-hour cough frequency and to assess safety and tolerability of NAL-ER for treatment of refractory chronic cough.
Phase: PHASE2 • Sponsor: Trevi Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Skin biopsies may reveal long COVID's hidden nerve damage
Knowledge-focused CompletedThis is a prospective, longitudinal study involving 300 participants for a single visit to compare Long COVID-19 neurocutaneous biosignatures with those of other disorders affecting the sensory and autonomic nervous system.
Sponsor: CND Life Sciences • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Wellness and peer support may boost HIV care for India's sexual minorities
Disease control OngoingThis study seeks to adapt and pilot test a comprehensive wellness program to address the barriers to engagement in the HIV care continuum among men who have sex with men (MSM) and transgender women (TGW) in India. The content involves an adaptation of the earlier Chetana wellness…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Personalized cancer vaccine trial halted early – what we know
Disease control TerminatedThe goal of this clinical trial is to learn about TLPO cancer vaccine in cases of solid tumor malignancies. The main objectives it aims to learn about are: * What is the time to progression/recurrence of disease after vaccination with the autologous TLPO vaccine in multiple soli…
Phase: PHASE2 • Sponsor: Elios Therapeutics, LLC • Aim: Disease control
Last updated Jun 26, 2026 16:56 UTC
-
Battle of the lenses: which contact lens best fights childhood nearsightedness?
Disease control CompletedThis is a one-year, mono-centre, randomize, double-masked, monocular cross-over clinical trial designed to test and compare the efficacy of the new lens design in slowing down the increase of axial length and controlling myopia progression.
Phase: NA • Sponsor: Essilor International • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a simple score cut down on unnecessary lung scans?
Diagnosis CompletedThe increased use of diagnostic imaging and especially computed tomography pulmonary angiography in patients suspected of pulmonary embolism (PE) is an important point of concerns. The goal of this pragmatic cluster-randomized trial is to compare the diagnostic strategy based on…
Phase: NA • Sponsor: University Hospital, Angers • Aim: Diagnosis
Last updated Jul 19, 2026 00:00 UTC
-
Gut bacteria could hold key to better colon cancer detection
Knowledge-focused Recruiting nowColorectal cancer (CRC) is a major public health problem, responsible for 2 million new cases and almost 1 million deaths annually worldwide. In Portugal, as of 2022, CRC is the most common cancer, with 10,575 new cases reported, and the second leading cause of cancer-related mor…
Sponsor: Gulbenkian Institute for Molecular Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Stomach bug battle: new drug combo could beat tough infections
Disease control Recruiting now1. Compare the efficacies and safety of 14-day bismuth-amoxicillin-vonoprazan tiple therapy, 14-day vonoprazan dual therapy and 14-day rabeprazole triple therapy in the first-line treatment of H. pylori infection. 2. To investigate the impacts of antibiotic resistance of H. pylor…
Phase: NA • Sponsor: Kaohsiung Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Eco-Friendly asthma inhaler passes safety check in major trial
Disease control CompletedThe CLI-05993AB6-03 Study is an interventional study designed to investigate the safety and efficacy of a new low global warming potential propellant (HFA-152a) compared to the currently approved one (HFA-134a) in the medication (CHF5993) in patients with moderate to severe asthm…
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug aims to protect kidneys in rare genetic disease
Disease control CompletedThe purpose of the study is to learn about the safety and tolerability of setanaxib in subjects with Alport syndrome, when added to their standard of care treatment. The study will assess how safe setanaxib is when compared to placebo. Study participants will be asked if they are…
Phase: PHASE1, PHASE2 • Sponsor: Calliditas Therapeutics AB • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Exercise may sharpen memory in adults who endured childhood trauma
Symptom relief Recruiting nowThis study aims to identify and compare the effects of acute and chronic exercise interventions on cognition in middle-aged adults with cognitive complaints and a history of abuse or neglect in childhood. Each participant will be enrolled in the study for up to 78 days, in five p…
Phase: NA • Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New study aims to help people with HIV quit smoking in south africa
Disease control Recruiting nowThe overall objective of the study is to optimize a smoking cessation treatment package for people with HIV (PWH) that can be integrated into existing HIV care in South Africa.
Phase: PHASE2, PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Ambulance pain drug showdown: ketamine vs fentanyl
Symptom relief Recruiting nowThe Prehospital Analgesia INtervention trial (PAIN) is a proposed 4 year (3-year enrollment) multicenter, prehospital, randomized, double-blind, clinical trial that will enroll approximately 994 patients at select LITES Network sites. The objective is to perform a prospective, in…
Phase: PHASE3 • Sponsor: Jason Sperry • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Could a One-Week radiation course be just as good as three weeks for breast cancer?
Disease control Completedbreast-conserving surgery. One group receives ultra-hypofractionated radiotherapy (26 Gy in 5 sessions over 1 week), while the other group receives hypofractionated radiotherapy (40 Gy in 15 sessions over 3 weeks). The study aims to compare skin toxicity, cosmetic outcomes, and l…
Phase: NA • Sponsor: Zagazig University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could cutting back on IV fluids save lives in septic shock?
Disease control Recruiting nowThe objective of this trial is to assess the beneficial and harmful effects of a restrictive strategy for administration of non-resuscitation fluids in adult patients with septic shock.
Phase: NA • Sponsor: Region Skane • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New scan could spot ALS sooner, study shows promise
Diagnosis CompletedAmyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, is a rare neurodegenerative disease resulting in loss, primarily, of the motor neurons in the motor cortex, brainstem and spinal cord. It currently affects 3 of every 100,000 people in the US. Currently, th…
Phase: PHASE1 • Sponsor: Université de Sherbrooke • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
BOTOX may slim the jaw without surgery
Symptom relief CompletedThe masseter muscle is one of the muscles in the lower face used for chewing. Prominence of the masseter muscle can appear as a widened and square lower face shape, which is an aesthetic concern for individuals who prefer a narrower and more ovoid lower face shape. Treatments are…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC